In vivo, inoculation of prostate cancer cells overexpressing MAO-A led to increased bone metastasis in mice, while cells with MAO-A genetic silencing delayed the onset of bone metastasis and extended mouse survival [124]. The gene discussed is MAOA; the disease is prostate carcinoma.